Coya Therapeutics, INC Form 4 insider transactions

CEO Howard Berman acquired stock options for 163,663 shares of Coya Therapeutics, Inc. on June 3, 2024.

Fred Grossman, Chief Medical Officer of Coya Therapeutics, acquired stock options for 70,596 shares of common stock on June 3, 2024.

Director Lee Ann reported the acquisition of 1,000 shares of Coya Therapeutics, Inc. common stock through a spouse's IRA.